Weak D type 67 in four related Canadian blood donors

1.Denomme GA, Wagner FF, Fernandes BJ, et al. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention. Transfusion 2005;45:1554–60.10.1111/j.1537-2995.2005.00586.x16181204Search in Google Scholar

2.Flegel WA, Roseff SD, Tholpady A. Phasing-in RHD genotyping. Arch Pathol Lab Med 2014;138:585–8.10.5858/2013-0509-ED517813824786114Search in Google Scholar

3.Flegel WA, Denomme GA. Allo- and autoanti-D in weak D types and in partial D. Transfusion 2012;52:2067–9.10.1111/j.1537-2995.2012.03693.x551270322946976Search in Google Scholar

4.Westhoff CM. Review: the Rh blood group D antigen... dominant, diverse, and difficult. Immunohematology 2005;21:155–63.10.21307/immunohematology-2019-412Search in Google Scholar

5.St-Louis M, Lebrun A, Goldman M, et al. Alloimmunization of patients by blood units harboring distinct DEL variants. Immunohematology 2013;29:136–40.10.21307/immunohematology-2019-136Search in Google Scholar

6.Flegel WA. The genetics of the Rhesus blood group system. Blood Transfus 2007;5:50–7.Search in Google Scholar

7.von Zabern I, Geisen C, Flegel WA. First observation of the RHD allele weak D type 67. Rhesusbase. Available at: http://www.ncbi.nlm.nih.gov/nuccore/FM201787. 2008.Search in Google Scholar

8.Wagner FF, Gassner C, Muller TH, et al. Molecular basis of weak D phenotypes. Blood 1999;93:385–93.10.1182/blood.V93.1.385Search in Google Scholar

9.Goldman M, Resz I, Cote J, et al. Identifying D-positive donors using a second automated testing platform. Immunohematology 2013;29:97–100.10.21307/immunohematology-2019-130Search in Google Scholar

10.Flegel WA, von Zabern I, Wagner FF. Six years’ experience performing RHD genotyping to confirm D– red blood cell units in Germany for preventing anti-D immunizations. Transfusion 2009;49:465–71.10.1111/j.1537-2995.2008.01975.x19243542Search in Google Scholar

11.Levine P, Celano M, Lange S, et al. The influence of gene interaction on dosage effects with complete anti-D sera. Vox Sang 1959;4:33–9.10.1111/j.1423-0410.1959.tb04309.x13648266Search in Google Scholar

12.Westhoff CM. Molecular genotyping for RHD: what (not) to do? Transfusion 2007;47:1337–9.10.1111/j.1537-2995.2007.01401.x17655574Search in Google Scholar